MBT-2 - Syngeneic Model

Rincon Bio performs MBT-2 syngeneic models to test efficacy of immunotherapies.  Please see below for additional information or to request a quote. 

Bladder

Organism: Mus musculus, mouse  Breed/subspecies: C3H/He  /  Tissue: Bladder  /  Disease: Transitional Cell Carcinoma

Notes

Mouse Bladder Tumor line-2

in vivo

Used as a syngeneic model.  Implanted tumor cells create a model in which to test the efficacy of novel immunotherapies 

Request Quote

Receive a quote within one business day for a MBT-2 syngeneic study

Rincon Bio Growth Curve

MBT2 Syngeneic Growth Curve.png

Cell Line: MBT2

Mouse Strain: CH3

Gender: female

Positive Control: Anti-PD1

Concentration: 2.5 & 5 mg/kg

Tumor target size for stratification: 50 mm^3

From implant to stratification: 10 days

Cells Implanted per Animal: 5x10^5

WHY WORK WITH

RINCON BIO?

DOMESTIC QUALITY at COMPETITIVE PRICES

 

When you work with Rincon Bio, rest assured that all cancer efficacy studies will be performed in the USA, at competitive prices

SPEED TO INITIATION
 

Most efficacy studies can be initiated within two business days.

PERSONAL TOUCH

 

We love our clients!  We take a personal interest in our clients and their studies.